EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Psychosomatic Disorders, Epigenome, and Gut Microbiota

Hamid Mostafavi Abdolmaleky iD, Ahmad Pirani, Giuseppe Pettinato iD

Cells · 2025

DOI: 10.3390/cells14241959 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Hamid Mostafavi Abdolmaleky und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Biomedical Genetics), Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Epigenome, Psychophysiologic Disorders, Epigenesis, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychosomatic disorders are conditions in which physical (somatic) symptoms are triggered or aggravated by psychological distress. These disorders result from complex interactions among the endocrine, central nervous, and immune systems. Emerging evidence indicates that gut microbiota (GM) dysbiosis, epigenetic alterations, and immune system dysregulation play pivotal roles in the pathogenesis of psychosomatic disorders and may serve as potential biomarkers for disease states and therapeutic outcomes. This review first outlines how epigenetic dysregulation contributes to psychosomatic disorders through altered expression of genes such as GRM2, TRPA1, SLC6A4, NR3C1, leptin, BDNF, NAT15, HDAC4, PRKCA, RTN1, PRKG1, and HDAC7. We then examine current evidence linking psychosomatic disorders with changes in GM composition and GM-derived epigenetic metabolites, which influence immune function and neurobiological pathways. The core focus of this review is on therapeutic interventions—including probiotics, prebiotics, postbiotics, fecal microbiota transplantation, and targeted dietary approaches—that modulate the gut–brain axis through epigenetic mechanisms for the management of psychosomatic disorders. Finally, we highlight the current challenges and future directions in elucidating the interplay between epigenetics, the GM, and psychosomatic disease mechanisms. In this context, human iPSC-derived multicellular organoids may serve as powerful platforms to unravel mechanistic pathways underlying inter-organ interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeEpigenomePsychophysiologic DisordersEpigenesis, GeneticHumansAnimals

Stichwörter der Autor:innen

epigeneticsgut microbiotamental distresspsychosomatic disorders

Autor:innen und Institutionen

  • Department of Medicine (Biomedical Genetics), Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Mental Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran 14535, Iran.

ORCID-Profile: Hamid Mostafavi Abdolmaleky, Giuseppe Pettinato

Zitieren

APA

Mostafavi Abdolmaleky, H., Pirani, A., & Pettinato, G. (2025). Psychosomatic Disorders, Epigenome, and Gut Microbiota. Cells. https://doi.org/10.3390/cells14241959

Vancouver

Mostafavi Abdolmaleky H, Pirani A, Pettinato G. Psychosomatic Disorders, Epigenome, and Gut Microbiota. Cells. 2025. doi:10.3390/cells14241959

BibTeX
@article{MostafaviAbdolmaleky2025,
  author = {Mostafavi Abdolmaleky, Hamid and Pirani, Ahmad and Pettinato, Giuseppe},
  title = {Psychosomatic Disorders, Epigenome, and Gut Microbiota},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14241959}
}
Kostenlos starten →